Is Neogenomics Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Neogenomics Inc (NEO) is currently classified as HALAL as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Neogenomics Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Neogenomics Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Neogenomics Inc?

Muslim investors may consider investing in Neogenomics Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Neogenomics Inc classified as HALAL?

Musaffa determines the Shariah status of Neogenomics Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Neogenomics Inc updated?

The Shariah compliance status of Neogenomics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Neogenomics Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Neogenomics Inc?

You can check the latest Shariah compliance status of Neogenomics Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

NEO Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: May 02, 2026

Report Source: 2026 1st Quarter Report

Neogenomics Inc. Stock Analysis NEO

United States Health Care Small Cap Report: Q1, 2026

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company is headquartered in Fort Myers, Florida and currently employs 2,500 full-time employees. The company went IPO on 2012-12-10. The firm offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. The company operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.

Key Statistics of Neogenomics Inc (NEO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$8.22$8.43

Today's Open

$8.39

Volume

1.11M

P/E Ratio (TTM)

52 Week Range

$4.72$13.74

Market Cap

1.15B

Avg. Volume

2.53M

Dividend Yield

Financial Metrics & Statements of Neogenomics Inc (NEO)

FAQ's for Neogenomics Inc (NEO)

According to Musaffa’s Shariah screening methodology, Neogenomics Inc (NEO) is currently classified as HALAL as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.